deltatrials
Completed OBSERVATIONAL NCT03363594

Indian Phenotype Registry (IP Registry)

A Non-interventional Nationwide Registry to Identify Indian Phenotype Characteristics in Diabetes Mellitus Patients in India.

Sponsor: AstraZeneca

Conditions Diabetes Mellitus
Updated 24 times since 2017 Last updated: Jun 12, 2020 Started: Dec 11, 2017 Primary completion: Jun 14, 2019 Completion: Jun 14, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Diabetes Mellitus and is currently completed. AstraZeneca leads this study, which shows 24 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Mar 2019 · 59 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshot~Aug 2019 – ~Jul 2020 · 11 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshot~Jan 2026 – ~Mar 2026 · 59 days · monthly snapshot~Mar 2026 – present · 4 months · monthly snapshot

Change History

24 versions recorded

  1. Mar 2026 — Present [monthly]

    Completed

  2. Jan 2026 — Mar 2026 [monthly]

    Completed

  3. Sep 2025 — Jan 2026 [monthly]

    Completed

  4. Sep 2024 — Sep 2025 [monthly]

    Completed

  5. Jul 2024 — Sep 2024 [monthly]

    Completed

▶ Show 19 earlier versions

  1. Jan 2021 — Jul 2024 [monthly]

    Completed

  2. Jul 2020 — Jan 2021 [monthly]

    Completed

  3. Aug 2019 — Jul 2020 [monthly]

    Completed

    Status: Recruiting → Completed

  4. Jun 2019 — Aug 2019 [monthly]

    Recruiting

  5. May 2019 — Jun 2019 [monthly]

    Recruiting

  6. Apr 2019 — May 2019 [monthly]

    Recruiting

  7. Mar 2019 — Apr 2019 [monthly]

    Recruiting

  8. Jan 2019 — Mar 2019 [monthly]

    Recruiting

  9. Dec 2018 — Jan 2019 [monthly]

    Recruiting

  10. Nov 2018 — Dec 2018 [monthly]

    Recruiting

  11. Sep 2018 — Nov 2018 [monthly]

    Recruiting

  12. Aug 2018 — Sep 2018 [monthly]

    Recruiting

  13. Jul 2018 — Aug 2018 [monthly]

    Recruiting

  14. Jun 2018 — Jul 2018 [monthly]

    Recruiting

  15. May 2018 — Jun 2018 [monthly]

    Recruiting

  16. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  17. Mar 2018 — Apr 2018 [monthly]

    Recruiting NA

  18. Feb 2018 — Mar 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  19. Dec 2017 — Feb 2018 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
Data source: AstraZeneca

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Agra, India , Ahilyanagar, India , Ahmedabad, India , Ajmer, India , Aligarh, India , Allahābād, India , Ambala, India , Amreli, India , Amritsar, India , Anand, India and 181 more locations